Business registries · firm from USPTO records

HARROW IP, LLC

USPTO only Derived from USPTO records only (patent assignees and trademark owners); FURP found no state registration, Form D, Form ADV, nonprofit, SEC or lobbying record with this name and place.

Place
42309 WINCHESTER ROAD, SUITE E, TEMECULA, CA
Entity type
Limited liability company
State of organization
DE (as the owner states it in trademark filings)
Patents
1 granted 2014-11-11 to 2019-10-17
Trademarks
33, 13 live
Record
EXACT high confidence: USPTO records only: patent assignee and trademark owner with the same name (legal endings aside) and place
Source
USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place

Patents

PatentTitleGrantedSource
US 12702651Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof2026-08-11PTBLXML, file of 2026-08-11
US 12594351Methods for increasing shelf-life of ophthalmic pharmaceutical compositions2026-04-07PTBLXML, file of 2026-04-07
US 12478639Ocular lubricant formulations2025-11-25PVGPATDIS, file of 2026-04-10
US 12443276Methods and system for remotely capturing media via a user interface bidirectionally linked to a remote server2025-10-14PVGPATDIS, file of 2026-04-10
US 12045386Methods and system for remotely capturing media via a user interface bidirectionally linked to a remote server2024-07-23PVGPATDIS, file of 2026-04-10
US 11918603Ocular lubricant formulations2024-03-05PVGPATDIS, file of 2026-04-10
US 11534481Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof2022-12-27PVGPATDIS, file of 2026-04-10
US 11338018Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof2022-05-24PVGPATDIS, file of 2026-04-10
US 11185546Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereof2021-11-30PVGPATDIS, file of 2026-04-10
US 11045432Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof2021-06-29PVGPATDIS, file of 2026-04-10
US 10993921Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof2021-05-04PVGPATDIS, file of 2026-04-10
US 10695351Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereof2020-06-30PVGPATDIS, file of 2026-04-10
US 10660891Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof2020-05-26PVGPATDIS, file of 2026-04-10
US 10561607Pharmaceutical compositions comprising gels and methods for fabricating thereof2020-02-18PVGPATDIS, file of 2026-04-10
US 10383875Pharmaceutical formulations of xanthine or xanthine derivatives, and their use2019-08-20PVGPATDIS, file of 2026-04-10

All patents of this assignee

Trademarks

MarkSerialFiledStatusClassesSource
MOXI-BROM886589222019-10-17Registered005TRTDXFAP, file of 2026-09-09
ZIAN885601212019-08-01Abandoned001TRCFECO2, file of 2024-03-27
KLARITY-B881800552018-11-02Registration cancelled005TRTDXFAP, file of 2026-08-12
HARROW HEALTH, INC.881786302018-11-01Registration cancelled005TRTDXFAP, file of 2026-05-13
(design)873925662017-03-30Registration cancelled005TRTYRAP, file of 2026-04-03
CORRECT COMPOUND871805222016-09-22Registration cancelled044TRTYRAP, file of 2026-04-03
PRED-GATI-NEPAF871805062016-09-22Registration cancelled005TRTYRAP, file of 2026-04-03
PRED-GATI871804922016-09-22Registration cancelled005TRTYRAP, file of 2026-04-03
IV FREE869665122016-04-06Registration cancelled041TRCFECO2, file of 2024-03-27
IMPRIMIS CARES!868670772016-01-06Registration cancelled044TRCFECO2, file of 2024-03-27
IMPRIMIS CARES868670422016-01-06Registration cancelled044TRCFECO2, file of 2024-03-27
DEX-MOXI868526082015-12-17Registered005TRTDXFAP, file of 2026-10-09
PRED-KETOR868525562015-12-17Registration cancelled005TRCFECO2, file of 2024-03-27
PRED-MOXI-KETOR868523412015-12-17Registration cancelled005TRCFECO2, file of 2024-03-27
IMPRIMIS PHARMACEUTICALS868106342015-11-05Registration cancelled044TRTDXFAP, file of 2026-10-09
GODROPLESS867599272015-09-17Registration cancelled041TRCFECO2, file of 2024-03-27
LESSDROPS867589232015-09-16Registration cancelled041TRCFECO2, file of 2024-03-27
ED FREE867303582015-08-19Registration cancelled041TRCFECO2, file of 2024-03-27
DEFEAT IC867288432015-08-18Registration cancelled041TRTDXFAP, file of 2026-04-25
TRI-MOXI867127692015-08-03Registration cancelled005TRCFECO2, file of 2024-03-27
STERICHECK866984812015-07-20Registration cancelled035TRTYRAP, file of 2026-04-03
ED FREE866941352015-07-15Registration cancelled005TRCFECO2, file of 2024-03-27
PPS-DR866712282015-06-23Registration cancelled005TRCFECO2, file of 2024-03-27
HLA866271392015-05-12Registration cancelled005TRCFECO2, file of 2024-03-27
TRIPLE DROP865610202015-03-11Registration cancelled005TRCFECO2, file of 2024-03-27

The newest 25 of 33. All marks of this owner

Sharing an address can mean a parent and subsidiary, a shared office or a registered agent; it isn’t proof of a connection.

Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.